Through a US$ 29 million grant, South Africa will receive enough medicine to provide HIV prevention to 450 000 people at high ...

South Africa has become the first African country, and our medicines regulator the third worldwide, to register the ...

It is believed the lenacapavir shot could end HIV/Aids in the country within 14 to 18 years if enough people were to take it.

South Africa has become the first African country – and our medicines regulator the third worldwide – to register the ...

JOHANNESBURG (AP) — South Africa's health minister on Tuesday called lenacapavir, the first twice-yearly HIV prevention jab in the world, a “groundbreaking” tool to fight the disease, but warned ...

The drug, Lenacapavir, is the world's first injectable Pre-Exposure Prophylaxis (PrEP). According to the World Health ...

By William Baloyi When President Donald Trump issued an executive order suspending all foreign aid to South Africa, in ...

South Africa has become the first African country to register lenacapavir, a groundbreaking six-monthly HIV prevention ...

EFF statement on South Africa registering the twice-a-year anti-HIV injection, Lenacapavir ...

HIV prevention drug Lenacapavir, which has been tested in South Africa during clinical trials, will be made available in the country in 2026 for high-risk groups.

PRETORIA, South Africa (AP) — It’s a worrying question for health officials in one of the richest and most developed areas of the African continent: Why are babies being born with HIV when free ...

South Africa has started distribution of the new anti-retroviral pill that combines three drugs to combat the HIV menace. The distribution began Sunday 1st of December 2019, to mark the World AIDS Day ...